Compare Blackstone Inc (BX) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Blackstone Inc vs Heron Therapeutics Inc — how do they compare? Blackstone Inc trades at $148 (market cap $117.44B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Blackstone Inc is far larger — about 1910.5× Heron Therapeutics Inc's market cap, and Blackstone Inc pays a 3.55% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BX | HRTX | |
|---|---|---|
Market Cap | $117.44B | $61.47M |
Sector | Financials | Health |
52-Week High | $188.68 | $1.49 |
52-Week Low | $102.12 | $0.32 |
Dividend Yield | 3.55% | — |
Enterprise Value | — | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Blackstone Inc
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
